T1DM Clinical Onset and Progression in Paediatric Population
Bioda
Determinants of Type 1 Diabetes (T1DM) Clinical Onset and Progression in Paediatric Immigrant Population
2 other identifiers
observational
94
1 country
3
Brief Summary
Diabetes Mellitus Type I is the chronic metabolic disease of childhood with the highest incidence in developed countries. Over the past 10 years the incidence of diabetes has been increased especially in immigrants children. The objective of the investigator's project is to evaluate factors that influence the T1DM course in immigrant and Italian children through an analysis of the relationship between socio-cultural determinants, lifestyles and metabolic control. The study population will consist of 100 children with first diagnosis of T1DM divided into two cohorts (Italian and immigrant children). The project consists in a follow-up of 18 months from first visit and will include laboratory tests, two questionnaires and determination of a microbiological indicator of the microbiota and levels of 25-hydroxyvitamin D. The research hypothesis is that the two groups of study population show a different metabolic control of diabetes due to differences in access to care, compliance to therapy and type of nutrition.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2015
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2015
CompletedFirst Submitted
Initial submission to the registry
March 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2017
CompletedFirst Posted
Study publicly available on registry
June 6, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 18, 2018
CompletedDecember 4, 2024
December 1, 2024
2.3 years
March 16, 2017
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic control
The blood pH of the patients are measured at the onset to define ketoacidosis following normal standard hospital procedure.
at onset
Secondary Outcomes (7)
Body mass index
at onset
Glycated hemoglobin
at onset
Diet behaviour
at onset
vitamin D
at the onset
Microbiome bioindicators
at onset
- +2 more secondary outcomes
Other Outcomes (1)
Metabolic control 2
at onset
Study Arms (2)
type 1 diabetes mellitus
Children with type 1 diabetes mellitus, usually not obese, with diabetic ketoacidosis. They could be with or without stationary metabolic profile. They are recruited at the onset of the T1DM into the Torino and Novara Pediatric Hospitals and then they are divided in relation to the ethnicity.
Control healthy
Healthy children without relevant metabolic or systemic co-morbility. They are recruited from orthopedy department of the Torino and Novara Pediatric hospitals and then they are divided in relation to the ethnicity
Eligibility Criteria
Children living in the Piedmont region. Primary care clinic of Torino and Novara (diabetologia for cases and orthopedia and general population for controls)
You may qualify if:
- Cases migrants : T1DM's recent diagnosis
- Italian cases : comparable to individual characteristics, living area, mainly age and gender
- Controls: healthy children (two control comparable for each case)
You may not qualify if:
- Children with parents of mixed origin
- Children with chronic gastrointestinal disorders (such as irritable bowel syndrome) or other relevant metabolic or systemic co-morbility
- Children who used antibiotics or with diarrhea in the last 15 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Pediatric Clinic - Hospital "Maggiore della Carità" of Novara
Novara, Italy
Dept. of Public Health and Pediatrics
Torino, 10126, Italy
Dep. of Medicine Science
Turin, Italy
Biospecimen
stool samples (from all the participants) and blood samples (only from T1DM) patients
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberta T Siliquini, Prof.
University of Turin - Hygiene and Preventive Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 18 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 16, 2017
First Posted
June 6, 2018
Study Start
March 18, 2015
Primary Completion
June 30, 2017
Study Completion
September 18, 2018
Last Updated
December 4, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share